Skip to content

Pioneering the discovery and development of cortisol modulators

Developing cortisol modulators for a broad range of serious diseases, including endocrine, metabolic, oncologic, and psychiatric disorders


Commitment toScience

We lead the field in the research and development of selective glucocorticoid receptor (GR) antagonists.

impact icon

Impact of excess cortisol and understanding GR antagonism

pill icon

Research & Pipeline


Commitment toPatients

We are committed to developing novel medications for patients suffering from diseases driven by cortisol dysregulation.

Learn More

Commitment toCulture

We foster a diverse and collaborative environment focused on developing novel therapies that help treat people with serious unmet medical needs.

Learn More